Chicago Partners Investment Group LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 204 filers reported holding IMMUNOGEN INC in Q4 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
Chicago Partners Investment Group LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q1 2023$102,947
-3.7%
25,482
+13.7%
0.01%
-14.3%
Q4 2022$106,877
-17.8%
22,406
-1.7%
0.01%
-22.2%
Q3 2022$130,000
+32.7%
22,794
+10.1%
0.01%
+28.6%
Q2 2022$98,000
+34.2%
20,695
-0.8%
0.01%
+16.7%
Q1 2022$73,000
-41.1%
20,856
-6.9%
0.01%
-33.3%
Q4 2021$124,000
-27.9%
22,394
-26.4%
0.01%
-25.0%
Q3 2021$172,000
-50.0%
30,417
-50.8%
0.01%
-7.7%
Q2 2021$344,000
+72.9%
61,874
+152.8%
0.01%
-18.8%
Q1 2021$199,00024,4770.02%
Other shareholders
IMMUNOGEN INC shareholders Q4 2022
NameSharesValueWeighting ↓
Redmile Group, LLC 13,063,767$35,403,0001.04%
QVT Financial LP 1,375,900$3,442,0000.87%
Virtus ETF Advisers LLC 50,045$136,0000.29%
Fernwood Investment Management, LLC 187,000$507,0000.27%
PURA VIDA INVESTMENTS, LLC 524,600$1,422,0000.20%
Endurant Capital Management LP 184,440$500,0000.20%
Birchview Capital, LP 90,000$244,0000.15%
TWIN FOCUS CAPITAL PARTNERS, LLC 112,873$306,0000.14%
DLD Asset Management, LP 1,239,500$3,347,0000.12%
DLD Asset Management, LP 1,186,300$3,215,0000.12%
View complete list of IMMUNOGEN INC shareholders